You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Business & Finance
Amgen announces Q1 2026 dividend
10 December 2025 -

Biopharmaceutical company Amgen (NASDAQ:AMGN) on Tuesday announced a dividend of USD2.52 per share for the first quarter of 2026.

This is an increase from the USD2.38 per share paid in each quarter of the prior year.

Shareholders of record at 13 February 2026 will receive the dividend on 6 March 2026.

Login
Username:

Password:


Related Headlines

Abbott declares quarterly dividend of USD0.63 per share

Gilead Sciences mobilises remdesivir donation to support Ebola response in Uganda

INOVIO's oartner ApolloBio reports positive topline results from Phase 3 trial of VGX-3100

Lilly declares Q2 2026 dividend

Collegium to acquire AZSTARYS from Corium Therapeutics

CVS Health announces quarterly dividend of USD0.665 per share

Convatec launches co-branded eakin freeseal ostomy seal in North America

UHS to acquire Talkspace for USD835m

Abbott announces quarterly dividend

Aptamer Optimer technology integrated into Twist Bioscience TrueAmp Library Preparation Kit

Alvotech reports positive PK study results for AVT80 biosimilar candidate

Inspiration Healthcare secures US purchasing agreement to drive Airon growth

West to sell SmartDose 3.5mL On-Body Delivery System rights to AbbVie for USD112.5m

Citius Pharmaceuticals reports full-year financial results

Sanofi receives FDA complete response letter for tolebrutinib in progressive MS

Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2026